Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727163
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2022-10-24
Brief Title:
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University